UpdatesPress Release
Biocon's consolidated income rose 9% to Rs 4,391 Cr, with net profit surging 355% to Rs 141 Cr.
Biocon LimitedBIOCON · Filed with the exchange
Biopharma revenue jumped 17% on new US/EU biosimilar/generic launches and EMA approval for its Malaysia plant, offsetting challenges in Services.
No comments yet. Be the first.